{"id":"W3212141161","doi":"10.1016/s2152-2650(21)02314-4","title":"P-187: Expert elicitation of long-term survival (LTS) for patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with idecabtagene vicleucel (ide-cel, bb2121) in the KarMMa phase 2 trial","year":2021,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pomalidomide; Multiple myeloma; Clinical trial; Expert opinion; Facilitator; Oncology; Internal medicine; Lenalidomide; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001617686,0.0005507455,0.001299278,0.0001419529,0.0002374657,0.00005008709,0.0005774593,0.0009243491,0.0001822725],"category_scores_gemma":[0.002142549,0.0003455748,0.0004567029,0.0006488907,0.0008824509,0.0001907115,0.0001184828,0.0004675364,0.00003064947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003044949,"about_ca_system_score_gemma":0.0007755385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009703247,"about_ca_topic_score_gemma":0.0002944536,"domain_scores_codex":[0.9942985,0.001847249,0.00179505,0.001059268,0.0002544902,0.0007454965],"domain_scores_gemma":[0.9920419,0.00556673,0.0007181651,0.0009230317,0.0006244392,0.0001257581],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1553256,0.008381658,0.09439742,0.0001045228,0.001006243,0.0002457266,0.0005218796,0.000003446886,0.02610496,0.0001485319,0.001330355,0.7124296],"study_design_scores_gemma":[0.2098352,0.01133046,0.727083,0.0002585416,0.0004192016,0.00004518708,0.0003658914,0.00008033521,0.04422432,0.00006201656,0.005614214,0.0006817032],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953939,0.0007480561,0.0008075893,0.0002907218,0.0007862149,0.001430745,0.0001667839,0.0000604757,0.000315553],"genre_scores_gemma":[0.9951451,0.0002276782,0.002052446,0.0009115146,0.000228711,0.0002129243,0.0006405467,0.00007007072,0.0005110258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7117479,"threshold_uncertainty_score":0.9998996,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05124793519729414,"score_gpt":0.3540276618320754,"score_spread":0.3027797266347813,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}